World wide use of psychotropic drugs in child and adolescent psychiatric disorders.
1. Questionnaires were mailed to child psychiatrists world wide to obtain more precise information on views and approaches to the diagnosis and treatment of childhood psychiatric disorders. 2. Results indicated important problems related to the management of child psychiatry practice both overseas and in Canada. 3. The choice of medication was frequently restricted by lack of availability, and political or social attitudes. 4. A consensus on diagnosis and treatment guidelines in child and adolescent psychiatry remains an important issue.
Simeon
J G
JG
Institute of Mental Health Research/Royal Ottawa Hospital, Ontario, Canada.
Wiggins
D M
DM
Williams
E
E
D000293:Adolescent; D000928:Antidepressive Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002170:Canada; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy; D004363:Drug Utilization; D005500:Follow-Up Studies; D005858:Germany; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D008774:Methylphenidate / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013557:Switzerland
D000928:Antidepressive Agents; D011619:Psychotropic Drugs; D008774:Methylphenidate; D007099:Imipramine